2017-02-02Zeitschriftenartikel
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
Krishna, B. A.; Spiess, K.; Poole, E. L.; Lau, B.; Voigt, Sebastian; Kledal, T. N.; Rosenkilde, M. M.; Sinclair, J. H.
Reactivation of human cytomegalovirus (HCMV) in transplant recipients can cause life-threatening disease. Consequently, for transplant recipients, killing latently infected cells could have far-reaching clinical benefits. ...